Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06600646

Investigating the Role of ATP Production by Airway Epithelium in Patients With Refractory and Unexplained Chronic Cough (RCC/UCC).

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
McMaster University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Chronic cough is a common troublesome symptom which has a global prevalence of approximately 10%, but with wide variations across continents. Patients with refractory and unexplained chronic cough (RCC/UCC) often exhibit dysregulated vagal pathways, necessitating a neuronal biomarker for targeted treatment. ATP, involved in the ATP/P2X3 pathway, may serve as a potential biomarker due to its role in the cough reflex. The study aims to discover if ATP production by the airway epithelium is greater in RCC/UCC patients compared with healthy controls, if the epithelium is a source of ATP, whether gene and protein expression related to ATP production differs between these groups and whether ATP release is triggered by mechanical and chemical stimulation. Additionally, the study seeks to determine if biomarker gene expression signatures can differentiate RCC/UCC patients from healthy controls.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBronchoscopyBronchoscopy will be performed in patients with refractory or unexplained chronic cough and healthy controls.

Timeline

Start date
2024-11-22
Primary completion
2025-10-01
Completion
2025-12-31
First posted
2024-09-19
Last updated
2025-05-08

Locations

1 site across 1 country: Canada

Regulatory

Source: ClinicalTrials.gov record NCT06600646. Inclusion in this directory is not an endorsement.